AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Repatha (Amgen) (repatha.com)
Repatha offers a substantive medical product packaged in an overly engineered ‘human-centric’ marketing shell. While the clinical data is robust and likely scientifically accurate, the site’s reliance on unverified patient stories and a total lack of structured data schema creates a measurable distance between its regulatory signal and its digital substance.
Replace the vague [H1] ‘Repatha® can help’ with a substance-led heading like ‘Repatha®: 63% Average LDL-C Reduction in 3 Months.’ Implement comprehensive Product and MedicalWebPage schema to bridge the technical authority gap. Add direct outbound citations to the peer-reviewed publications for the FOURIER or cardiovascular outcomes trials mentioned. Replace the robotic Sam metaphor with a technical ‘Mechanism of Action’ section to increase expert-level information density.
The information density is a tale of two extremes. Headings like [H1] ‘Repatha® can help’ and [H3] ‘BECAUSE YOU’RE HUMAN’ are pure emotional fluff with 0% substance. However, the body text is packed with highly specific clinical evidence, such as the ‘63% average reduction’ in LDL-C and the ‘27%’ reduction in heart attack risk. The score is penalised for high concept repetition regarding the Co-Pay card across all four pages.
When chunking fails, embeddings degrade, retrieval collapses, and your content loses every competitive comparison. Generate your Semantic HTML Audit to quantify the structural friction that blocks AI comprehension.
There is minor semantic drift between the homepage’s high-level ’emotional support’ signals and the sub-page’s granular ‘clinical trial’ data. While the homepage focuses on the user’s journey and ‘letting us tell you more about you,’ the ‘What is Repatha’ page shifts into hard medical statistics. The alignment is generally strong, but the transition from patient-lifestyle marketing to technical pharma data is abrupt.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site exhibits high Trust Theatre. While it features ‘real Repatha patients’ like Cathy and Jerry, these testimonials are presented with a review_count of 2-4 but a proof_links_count of 0, meaning the ‘success stories’ lack external verification paths or linked case study documentation. The trust_theatre_flag is true across all pages because of these unsubstantiated patient efficacy claims.
Proof density is high regarding internal metrics but low regarding external validation. The site provides at least 6 specific clinical data points (63%, 84%, 27%, 21%, 55%, 36%), which is excellent substance, but provides 0 external proof links in the structured data. This creates a closed-loop authority structure where the user must trust Amgen’s self-reported summaries.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The site relies heavily on industry cliches and value prop cliches like ‘breakthrough medicine’ and ‘Where science meets compassion’ (implied by the robot Sam metaphor). The Sam the Robot narrative is a textbook pharma template for ‘humanising’ a drug. Furthermore, the ‘Important Safety Information’ and ‘Approved Use’ blocks are necessary but follow a standardized boilerplate fingerprint found across the entire pharmaceutical sector.
There is a significant technical authority gap; despite being a major global drug, the schema_json is null across all pages, missing critical Organization or Product structured data. While ‘Cathy’ and ‘Jerry’ are cited as authorities of experience, they have no digital footprint or Person schema. The site lacks outbound links to the specific peer-reviewed studies mentioned, relying instead on internal text assertions.
The marketing tone uses bold assertions like ‘dramatically lower bad cholesterol,’ but unlike generic BS sites, Repatha actually backs this with specific numbers (84% of patients below 55 mg/dL). The disconnect is not in the truth of the claims, but in the lack of direct citations to ClinicalTrials.gov or published journals within the body text to verify the ’10 Years of Impact’ claim.
Medical Devices, Pharma & Biotech BS: Repatha (Amgen) (repatha.com)
The site perfectly matches the Pharma & Biotech industry, evidenced by extensive ‘Important Safety Information’ blocks, ‘Approved Use’ declarations, and specific clinical data metrics for evolocumab. It follows high-compliance regulatory patterns typical of FDA-regulated prescription medication pages.
AI retrieval begins with one question: "What is this page?" Read the Structured Data Technical Guide to learn how correct entity typing and persistent identifiers prevent your site from collapsing into noise.
“The score of 39 is driven primarily by the Commodity Fingerprint (11) and Trust Theatre (8) pillars. While the site is medically substantive, its marketing delivery is highly derivative of standard pharma templates and it fails to provide verifiable links for its patient reviews or implement modern technical authority signals (Schema).”